Authors' Reply [0.03%]
作者回复
Shuai Xiang
Shuai Xiang
Redlining, Structural Racism, and Psoriatic Arthritis Outcomes: Underrecognized Limitations and Clinical Implications [0.03%]
红线条、结构种族主义与银屑病关节炎结局：未被充分认识的局限性和临床意义
Shiuan-Chih Chen,Yuan-Ti Lee
Shiuan-Chih Chen
Interleukin-33 Promotes Interstitial Lung Disease in Idiopathic Inflammatory Myopathy via ERK-Mediated Epithelial-Mesenchymal Transition: ERK as a potential therapeutic target [0.03%]
白细胞介素33通过ERK介导的上皮间质转化促进炎性肌病相关间质性肺疾病：ERK作为潜在治疗靶点
Jumei Yang,Wenjun Li,Jiarui Zhu et al.
Jumei Yang et al.
Objectives: Interstitial lung disease (ILD) is the most common and prognostically severe complication of idiopathic inflammatory myopathy (IIM), for which targeted treatments remain limited. Based on previous findings tha...
Reply to Redlining, Structural Racism, and Psoriatic Arthritis Outcomes [0.03%]
关于红皮病、结构种族主义和银屑病关节炎的回信
Sharon Dowell,Emily E Holladay,Jeffrey R Curtis et al.
Sharon Dowell et al.
Letter to Editor: The limitations on Urate's Role in Knee Osteoarthritis Studies [0.03%]
论著来信：尿酸在膝骨关节炎研究中的局限性
Qing Wang,Shuxing Xing
Qing Wang
Are Glucocorticoids Associated with Worse Survival among Rheumatoid Arthritis Patients with Lung Cancer Treated with Immune Checkpoint Inhibitors? [0.03%]
糖皮质激素会降低类风湿关节炎患者免疫检查点抑制剂治疗肺癌的生存率吗？
Deanna Jannat-Khah,Jeffrey R Curtis,Fenglong Xie et al.
Deanna Jannat-Khah et al.
Objective: Glucocorticoids are commonly used for rheumatoid arthritis (RA) treatment and to palliate some malignancies, but it is unclear whether glucocorticoids attenuate the benefits of immune checkpoint inhibitor (ICI)...
Drugs induced Raynaud's phenomenon and underlying mechanism: a disproportionality analysis from the WHO pharmacovigilance database [0.03%]
基于WHO药品不良反应数据库的药物所致雷诺现象及可能机制的信号检测分析研究
Alex Hlavaty,Loubna Dari,Jean-Luc Cracowski et al.
Alex Hlavaty et al.
Objectives: The aim of this study is to generate hypotheses about unknown drugs associated with the onset or worsening of Raynaud's Phenomenon (RP) and to explore their potential pathophysiological mechanisms through a mi...
Karen H Costenbader,Zahi Touma,Marta Mosca
Karen H Costenbader
Distinct effects of complement C4A and C4B copy number in Systemic Sclerosis serological and clinical subtypes [0.03%]
补体C4A和C4B在系统性硬化症血清学和临床亚型中的不同效应
Javier Martínez-López,Carlos Rangel-Peláez,Inmaculada Rodriguez-Martin et al.
Javier Martínez-López et al.
Objective: Complement component 4 (C4), encoded by C4A and C4B within the major histocompatibility complex (MHC) on chromosome 6, regulates the immune response and clears immune complexes. Variable copy number (CN) of C4 ...
Christian Beyer,Bernhard Manger,Marion Ganslmayer et al.
Christian Beyer et al.